Myocardial infarctions (MIs) occur in more than 1 million people in the United States each year. Approximately 60% of MI sufferers survive, and require special care, since MI may lead to disability and put the patient at an increased risk for comorbid conditions. Now in its third edition, this authoritative text presents options for rehabilitation, drug therapy, and schedules for laboratory testing for surviving MI patients, as well as pharmacologic treatment choices.